Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (588)

51

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer : primary results from cohort B of the IPATunity130 randomized phase 3 trial

enthalten in: Breast cancer research and treatment | 2022

von Turner, N. | Dent, R. | O'Shaughnessy, J. | +13

52

Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer : An NRG oncology/gynecologic oncology group study

enthalten in: Gynecologic oncology | 2022

von duPont, N. | Enserro, D. | Brady, M. | +13

53

Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-021 with reference bevacizumab

enthalten in: BMC cancer | 2022

von Stroyakovskiy, D. | Fadeeva, N. | Matrosova, M. | +9

54

Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Schneeweiss, A. | Michel, L. | Möbus, V. | +20

55

Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors : post hoc analysis of IMpower150

enthalten in: British journal of cancer | 2022

von Hopkins, A. | Kichenadasse, G. | McKinnon, R. | +6

56

Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens

enthalten in: International journal of cancer | 2022

von Quintanilha, J. | Wang, J. | Sibley, A. | +14

57

A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

enthalten in: Annals of surgery | 2022

von Hewitt, D. | Nissen, N. | Hatoum, H. | +18

CommentIn: Hepatobiliary Surg Nutr. 2021 Aug;10(4):534-537. - PMID 34430537

58

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer : 2-year update of the randomized phase 3 KEYNOTE-061 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2022

von Fuchs, C. | Özgüroğlu, M. | Bang, Y. | +17

59

Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia) : a randomised, multicentre, double-blind, phase 3 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2021

von Xu, R. | Zhang, Y. | Pan, H. | +14

60

Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL) : a randomised, multicentre, open-label, phase 3 trial

enthalten in: The lancet. Healthy longevity | 2021

von Kogure, Y. | Iwasawa, S. | Saka, H. | +19

CommentIn: Lancet Healthy Longev. 2021 Dec;2(12):e774-e775. - PMID 36098034